How we approach thrombosis risk in children with COVID-19 infection and MIS-C.
Pediatr Blood Cancer
; 68(7): e29049, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1217408
ABSTRACT
Thrombosis within the microvasculature and medium to large vessels is a serious and common complication among critically ill individuals with coronavirus disease 2019 (COVID-19). While children are markedly less likely to develop severe disease than adults, they remain at risk for thrombosis during acute infection and with the post-acute inflammatory illness termed multisystem inflammatory syndrome in children. Significant knowledge deficits in understanding COVID-19-associated coagulopathy and thrombotic risk pose clinical challenges for pediatric providers who must incorporate expert opinion and personal experience to manage individual patients. We discuss clinical scenarios to provide framework for characterizing thrombosis risk and thromboprophylaxis in children with COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Thrombosis
/
Systemic Inflammatory Response Syndrome
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
/
Anticoagulants
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Language:
English
Journal:
Pediatr Blood Cancer
Journal subject:
Hematology
/
Neoplasms
/
Pediatrics
Year:
2021
Document Type:
Article
Affiliation country:
Pbc.29049
Similar
MEDLINE
...
LILACS
LIS